Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities Pharmaceutical Investing
Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130 Pharmaceutical Investing
Promise of BetterLife's Non-hallucinogenic LSD For Treating Mood Disorders Highlighted in Medical Xpress Article Pharmaceutical Investing
Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analysts Life Science Investing
Kite's Yescarta® CAR T-cell Therapy Demonstrates a Statistically Significant Improvement in Overall Survival for Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma Pharmaceutical Investing
Gilead Exercises Option to License Nurix's IRAK4 Targeted Protein Degrader Development Candidate, NX-0479 Pharmaceutical Investing
InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer Pharmaceutical Investing
